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Binding of aminoglycoside antibiotics to 16S ribosomal RNA
induces a particular structure of the decoding center and
increases the misincorporation of near-cognate amino acids.
By kinetic analysis we show that this is due to stabilization of
the near-cognate codon recognition complex and the accel-
eration of two rearrangements that limit the rate of amino
acid incorporation. The same rearrangement steps are accel-
erated in the cognate coding situation. We suggest that cog-
nate codon recognition, or near-cognate codon recognition
augmented by aminoglycoside binding, promote the transi-
tion of 16S rRNA from a ‘binding’ to a ‘productive’ confor-
mation that determines the fidelity of decoding.
The ribosome is composed of two subunits — the small sub-
unit (30S in bacteria) that is the site of codon–anticodon inter-
action and the large subunit (50S) that catalyzes peptide bond
formation between aminoacyl-transfer RNA (aa-tRNA) bound
to the A site and peptidyl-tRNA bound to the P site. During
translation, the aa-tRNA is bound to the A site in a GTP-depen-
dent process that is catalyzed by elongation factor Tu (EF-Tu).
Aminoacyl-tRNA (aa-tRNA) selection in response to the codon
in the ribosomal A site takes place at two points: before GTP
hydrolysis of EF-Tu (initial selection) and after GTP hydrolysis
but before peptide bond formation (proofreading). During ini-
tial selection, noncognate aa-tRNA•EF-Tu•GTP complexes that
do not induce GTP hydrolysis are rejected. When a cog-
nate codon is recognized, that is, when three base pairs
are formed between codon and anticodon, the GTPase
of EF-Tu is activated, GTP is hydrolyzed and aa-tRNA is
released from EF-Tu•GDP1. The aminoacyl end of aa-
tRNA is then free to move into the peptidyl transferase
center on the 50S subunit (accommodation) and to take
part in peptide bond formation (Fig. 1). A similar
sequence of events occurs when a near-cognate codon is
recognized, that is, when the codon–anticodon match is
imperfect. However, in such a case, following GTP
hydrolysis and release from EF-Tu, near-cognate aa-
tRNA dissociates from the ribosome rather than enter-
ing the peptidyl transferase center. The efficiency of
near-cognate aa-tRNA rejection in initial selection and
proofreading is determined by both the lower stability
of the codon–anticodon complex and slower forward
reactions (GTPase activation and accommodation),
compared to the cognate situation2.
The decoding center of 16S ribosomal RNA (rRNA)
has an essential role in maintaining the fidelity of aa-
tRNA selection by the ribosome3–5. Aminoglycoside
antibiotics such as paromomycin, gentamicin and
neomycin decrease the fidelity of decoding6 by binding to the A
site of the decoding center7 and inducing a structural change of
the binding site7,8. These findings indicate a link between the
conformation of 16S rRNA and decoding. The antibiotics are
bound in the major groove of the A site rRNA within a pocket
created by the A1408•A1493 base pair and the bulged A1492.
The three adenines are protected from dimethyl sulfate (DMS)
modification by mRNA-dependent tRNA binding to the A site,
indicating that the decoding center is probably in direct contact
with the codon–anticodon complex9–12. Therefore, it has been
suggested that paromomycin induces a conformation of 16S
rRNA that binds tRNA to the A site with high affinity7. This
would increase the error frequency by stabilizing the binding of
aa-tRNA13. Indeed, it has been reported that the antibiotic
decreases the rate of tRNA dissociation from the A site about
six-fold14. However, this effect is too small to explain the
aminoglycoside-induced increase of misreading, which ranges
from 10- to 200-fold, depending on the codon and the antibiot-
ic6. Thus, it appears that additional effects are involved. This is
addressed here by kinetic analysis.
To first assess the effect of paromomycin on the initial stage of
discrimination of noncognate ternary complexes, GTP hydroly-
sis rates were measured when the ternary complex, 
EF-Tu•GTP•Phe-tRNAPhe, was bound to ribosomes pro-
grammed with different mRNAs. With poly(A)-programmed
ribosomes that display a noncognate AAA codon in the A site,
the antibiotic enhanced the rate of GTP hydrolysis about two-
fold, with a concomitant increase of KM by about a factor of two
(Fig. 2). The same result was obtained with unprogrammed,
vacant ribosomes. Similarly, GTP hydrolysis in the binary com-
plex, EF-Tu•GTP, on the ribosome was stimulated about two-
fold (data not shown). Hence, paromomycin increases the
kcat/KM value for noncognate ternary complexes about four
times, because of the two-fold increase of both kcat and KM of the
GTPase reaction. There is no significant change of kcat/KM in the
cognate coding situation with poly(U) (88 versus 86 m M-1 s-1), as
calculated from elemental rate constants determined in the absence
and presence of paromomycin (ref. 2 and data not shown). Initial
selectivity is defined as (kcat/KM)correct/(kcat/KM)incorrect of the
GTPase; hence paromomycin in the noncognate poly(A) system
Fig. 1. Kinetic scheme of aa-tRNA binding to the ribosomal A site. EF-Tu (light
green) is depicted in three conformations: the GTP form with aa-tRNA bound to
it, the transient GTPase-activated form on the ribosome (G domain dark green)
and the GDP-bound form that dissociates from the ribosome.
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reduces the initial selectivity about four-fold.
In order to study the influence of paromomycin on GTP
hydrolysis in different coding situations, we used mRNA-pro-
grammed 70S initiation complexes displaying various codons in
the A site. To these complexes, ternary complex (EF-
Tu•GTP•Phe-tRNAPhe) was added, and the rate of GTP hydroly-
sis was measured in the absence and presence of paromomycin.
In the absence of antibiotic, GTP hydrolysis was slow
(0.002–0.003 s-1) with all noncognate codons (no base pair pos-
sible) as well as with the UUG:AAG pair featuring a guanine-
guanine apposition in the third codon position (Leu 5; Table 1).
In these cases, where anticodon and codon do not match suffi-
ciently to induce fast GTPase, paromomycin slightly (up to
three-fold) stimulated EF-Tu-dependent GTP hydrolysis on the
ribosome (Table 1). Similarly, for the near-cognate CUU:AAG
complex, with a mismatch in the first and a wobble base pair in
the third codon position, the stimulation by paromomycin of
the rate of GTP hydrolysis was about four-fold (Table 1). These
effects are small in view of the reported finding that paro-
momycin strongly increases the misreading of near-cognate
codons15.
In order to quantitatively assess the effect of paromomycin on
ribosomal accuracy, we have analyzed in full the kinetics of
A site binding of near-cognate ternary complex in the presence
Fig. 2 Paromomycin effect on GTP hydrolysis. Values for kapp of GTP
hydrolysis in the ternary complex, EF-Tu•GTP•Phe-tRNAPhe, on poly(A)-
programmed ribosomes were measured in the absence (P) and presence
(P) of paromomycin. Ternary complex (0.1 m M) and ribosomes were incu-
bated at 20°C for up to 30 min; apparent rate constants were obtained
by single-exponential fitting. Saturation levels represent first-order rate
constants of GTP hydrolysis, 0.008 s-1 and 0.014 s-1, in the absence and
presence of paromomycin, respectively.
Fig. 3. Kinetics of Leu 2 binding in the presence of paromomycin. a, Initial binding. kapp values were obtained by exponential fitting of time courses
of EF-Tu•GTP•Leu-tRNALeu2(Prf16/17/20) binding to poly(A)-programmed ribosomes measured by fluorescence stopped flow. The dependence of kapp
on ribosome concentration gives k1 = 140 ± 20 m M-1 s-1 (slope) and k-1 = 25 ± 10 s-1 (ordinate intercept). b, Determination of k-2. The codon recognition
complex was prepared from EF-Tu•GDPNP•Leu-tRNALeu2(Prf16/17/20) and poly(U)-programmed ribosomes with AcPhe-tRNAPhe in the P site. The dis-
sociation of the complex was initiated by adding of a 10-fold excess of nonfluorescent EF-Tu•GDPNP•Phe-tRNA Phe and monitored in the stopped-
flow apparatus. Single-exponential fitting yields k-2 = 3.5 ± 0.5 s-1. c, Conformational changes of aa-tRNA. A-site binding was monitored by the
fluorescence of Leu-tRNALeu2(Prf16/17/20). Time courses obtained with 0.3 (1), 0.5 (2) and 1.5 m M (3) of poly(U)-programmed, P site-blocked ribo-
somes are shown. d, GTP hydrolysis and dipeptide formation. GTP hydrolysis by EF-Tu•[ g -32P]GTP•[3H]Leu-tRNALeu2 was measured with 0.3 m M (P),
0.5 m M (p)and 1.5 m M (G) poly(U)-programmed, P site-blocked ribosomes; AcPhe-[3H]Leu formation with 1.5 m M ribosomes (L); dipeptide formed in
the absence of antibiotic is shown for comparison (r)2. Data sets used for global fitting were combined from data shown in (c) and (d) as well as
from additional data obtained at 1.0 m M and 2.0 m M ribosomes. Smooth lines in c and d are calculated from elemental rate constants (Table 2).
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of paromomycin. For the kinetic analysis, we used poly(U)-pro-
grammed ribosomes and Leu-tRNALeu2 (anticodon GAG),
because a complete set of rate constants was available for this
system2. Kinetic data were obtained by fluorescence stopped
flow using proflavin-labeled Leu-tRNALeu2(Prf16/17/20) and by
quench flow (GTP hydrolysis and dipeptide formation). In par-
allel, the kinetic effects of paromomycin in the cognate situation
with Phe-tRNAPhe were also analyzed. In order to allow the eval-
uation of the kinetic scheme (Fig. 1) by fitting (see below), three
rate constants (k1, k-1 and k-2) were measured directly and used
as fixed values in the fit. Those rate constants were determined
as follows.
Codon-independent initial binding of EF-Tu•GTP•Leu-tRNALeu2
to ribosomes, characterized by rate constants k1 and k-1 (ref. 16),
was measured at different concentrations of ribosomes pro-
grammed with poly(A). Apparent rate constants (kapp) were
obtained by exponential fitting, and rate constants were deter-
mined from the linear concentration dependence of kapp (Fig. 3a).
For the association rate constant, k1, a value of 140 m M-1 s-1 was
obtained in the presence of paromomycin that was comparable
to the value obtained in the absence of antibiotic, 110 m M-1 s-1
(ref. 2). The dissociation rate constant, k-1, was the same with or
without paromomycin (25 s-1).
The dissociation rate constant of the codon recognition com-
plex, k-2, was determined by measuring the dissociation rate of
the complex formed in the presence of a non-
hydrolyzable GTP analog, GDPNP. In that 
complex, A site binding is blocked after codon
recognition, while the kinetics of initial bind-
ing and codon recognition are unaffected17. 
The preformed codon recognition complex, 
EF-Tu•GDPNP•Leu-tRNALeu2 (Prf16/17/20) on
poly(U)-programmed ribosomes was rapidly
mixed with a 10-fold excess of unlabeled 
EF-Tu•GDPNP•Phe-tRNAPhe in the stopped-flow
apparatus. A single-exponential fluorescence
decrease to the level of unbound ternary com-
plex was observed (Fig. 3b). The value of the
time constant obtained (k-2 = 3.5 s-1) is about
five times smaller than the value obtained in the
absence of the antibiotic (17 s-1; ref. 2), indicat-
ing a stabilization by paromomycin of the codon
recognition complex.
The remaining elemental rate constants of
the scheme depicted in Fig. 1 were obtained by
global fitting (refs 1,2); that is, all time courses
measured with different observables at various
ribosome concentrations (Fig. 3c,d) were
included in the fit. The rate constants k4, k5 and k7 were also
obtained analytically from the length of the lag phase, the rate,
and the extent of dipeptide formation (Fig. 3d). Rate constants
are summarized in Table 2. For comparison, the previously
determined rate constants of Leu-tRNALeu2 binding to the A site
in the absence of antibiotic2, which were confirmed here, are
included. Note that paromomycin affects all steps, except initial
binding (step 1). In agreement with previous data14, the stability
of the codon–anticodon interaction is increased as evident from
the five- to six-fold decrease of the rate constants of both ternary
complex (k-2) and aa-tRNA (k7) dissociation. Furthermore, k2,
the rate constant of codon recognition, is reduced about three
times. The same effect of paromomycin was observed with cog-
nate ternary complex containing Phe-tRNAPhe (data not
shown). The rate constant of GTPase activation, k3, and the rate
of GTP hydrolysis, is increased more than 10-fold, to >500 s-1,
up to the level observed in the cognate situation without antibi-
otic1 or with paromomycin (data not shown). As a consequence,
the initial selection will be abolished in the presence of paro-
momycin, despite the decrease of k-2.
The rate constant for the conformational switch of EF-Tu
from the GTP to the GDP conformation, k4, is decreased 
~10-fold when paromomycin is present. The same decrease was
observed in the cognate situation (data not shown). This effect
suggests that the 30S subunit could influence EF-Tu, possibly by
a direct contact (ref. 3) that is modulated by paromomycin
binding. However, because the conformational change of EF-Tu
is not rate limiting for the subsequent steps (Table 1), it has no
relevance for selection. Functionally the most important effect
of paromomycin is that it increases the accommodation rate
constant, k5, by a factor of 10 and, at the same time, decreases
the rate constant of aa-tRNA rejection in the proofreading
phase, k7, about six-fold. As a result, the two rate constants are
about equal, 0.9 and 1 s-1, respectively. Thus, 50% of leucine is
incorporated into dipeptide in the presence of paromomycin,
about 30 times the level (1.5%) observed in the absence of
antibiotic2 (Fig. 3d). The increased level of leucine misincorpo-
ration induced by paromomycin under the present experimen-
tal conditions (no initial selection) is explained by both the
failure of rejection and the acceleration of A site accommoda-
Table 1 Effect of paromomycin on GTP hydrolysis
Codon 5' to 3' (tRNA) GTP hydrolysis rate1 (s-1)
-Paromomycin +Paromomycin
AGA (Arg) 0.002 ± 0.001 0.003 ± 0.001
UCA (Ser) 0.003 ± 0.001 0.007 ± 0.001
UAU (Tyr) 0.003 ± 0.001 0.003 ± 0.001
UUG (Leu5) 0.002 ± 0.001 0.007 ± 0.001
CUC (Leu2) 0.07 ± 0.02 0.29 ± 0.01
UUU (Phe) 6.5 ± 0.1 3.8 ± 0.3
1EF-Tu•[ g -32P]GTP•Phe-tRNAPhe (anticodon 3'-AAG-5') (0.1 m M) was
bound to mRNA-programmed 70S initiation complexes (0.2 m M; for CUC
and UUU, 1 m M) displaying various codons in the A site and GTP hydroly-
sis measured as described in Methods.
Table 2 Elemental rate constants of near-cognate EF-Tu•GTP•Leu-tRNALeu2
binding to the A site
Step1 Rate constant (s-1)
-Paromomycin2 +Paromomycin
Initial binding k1 110 ± 20 (ftn. 3) 140 ± 20 (ftns 3,4)
k-1 25 ± 5 25 ± 10 (ftn. 4)
Codon recognition k2 100 ± 20 37 ± 2
k-2 17 ± 8 3.5 ± 0.5 (ftn. 5)
GTPase activation and GTP hydrolysis6 k3 50 ± 20 >500 (ftn. 7)
GTP-GDP conf. change of EF-Tu k4 50 ± 20 6 ± 2
aa-tRNA accommodation and
peptide bond formation6 k5 0.1 ± 0.03 1 ± 0.1
Dissociation of EF-Tu•GDP k6 2 ± 1 ND8
aa-tRNA rejection k7 6 ± 1 0.9 ± 0.2




4Determined independently (Fig. 3a).
5Determined independently (Fig. 3b).
6Grouped for global analysis, because the former reaction is rate limiting1,2.
7Rate too fast to be resolved.
8Not determined.
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tion of near-cognate Leu-tRNALeu2 during the proofreading step.
It seems likely that the basic mechanism of aminoglycoside-
induced misincorporation, as described here for Leu 2 on UUU
codons and paromomycin, applies also to other near-cognate
situations and other aminoglycosides, although there may be
quantitative differences.
There are two possible ways to explain the effect of paro-
momycin in molecular terms. The antibiotic may directly inter-
act with the anticodon region of the aa-tRNA and/or the
mRNA18 or, alternatively, it may induce a conformation of 16S
rRNA such that 16S rRNA interactions with tRNA and/or
mRNA are favored7,12. While both interpretations seem consis-
tent with the observed stabilization by paromomycin of near-
cognate aa-tRNA binding, the former does not explain the
three-fold slower codon recognition observed in the presence of
paromomycin. The former model is also difficult to reconcile
with the acceleration observed for the forward reactions of
GTPase activation and A site accommodation. Thus, the model
involving a conformational switch of 16S rRNA seems more
likely. The switch may extend beyond the decoding center, as
recent X-ray crystallographic models of 30S ribosomal sub-
units19 or of 70S ribosomes20 suggest a close contact of the
decoding region of 16S rRNA (helix 44) with helix 27 of 16S
rRNA, another region that is involved in a switch regulating
accuracy5.
Interestingly, the same steps that are affected by paro-
momycin, that is, GTPase activation and A site accommodation,
are much faster in the cognate situation than in the near-cog-
nate one, suggesting an induced-fit mechanism of selection2. In
order to rationalize induced fit in terms of structure, we suggest
that the formation of the codon–anticodon complex induces a
conformational transition of 16S rRNA that is similar to that
caused by aminoglycoside binding and, in the cognate situation,
is favored by structure-specific, sequence-independent interac-
tions. Such contacts, which would increase the stability of the
complex, could be formed between the A site 16S rRNA and the
sugar-phosphate backbone of the codon–anticodon complex or
residues of the codon–anticodon duplex that are in the same
positions in all Watson–Crick base pairs. One prediction of the
model is that codon recognition should be impaired when the
antibiotic is bound. This is in fact observed, as the rate constant
of codon recognition (k2) is reduced about three-fold in the
presence of paromomycin for both Leu 2 (Table 2) and Phe
(data not shown). The model assumes that the conformational
transition of 16S rRNA induced by cognate codon–anticodon
complex formation is structurally coupled to the acceleration of
GTPase activation and A site accommodation of aa-tRNA,
although the mechanism of coupling is not clear at present. The
near-cognate codon–anticodon complex would be less efficient
in promoting the transition of 16S rRNA toward the productive
conformation, and binding of paromomycin to the decoding
center would be additionally required to induce the productive
conformation of 16S rRNA.
Methods
Materials were prepared and GTP hydrolysis was measured as
described1,2. EF-Tu•[ g -32P]GTP•[14C]Phe-tRNAPhe and EF-Tu•[ g -
32P]GTP complexes were purified by gel filtration on Superdex 75
(Pharmacia). mRNAs (about 120 nucleotides long) contained simi-
lar ribosome binding sites and different codons following the
AUG initiation codon (Table 1). mRNAs were prepared by runoff
T7 RNA polymerase transcription of plasmids derived from plas-
mid pXR022 (ref. 21), provided by C. Gualerzi and R. Spurio
(University of Camerino, Italy), or of plasmids coding for b -lacta-
mase provided by G. Rauch (University of Witten, Germany). 70S
initiation complexes with f[3H]Met-tRNAfMet in the P site were pre-
pared in buffer A (50 mM Tris-HCl, pH 7.5; 70 mM NH4Cl; 30 mM
KCl; 7 mM MgCl2, 1 mM dithiothreitol, DTT) as described22. Time
courses of GTP hydrolysis (Fig. 2; Table 1) were measured at 20 °C
either manually or by quench flow (Leu 2, Phe) with 0.1 m M EF-
Tu•[ g -32P]GTP•[14C]Phe-tRNAPhe; the concentration of initiation
complexes usually was 0.3 m M, except for Leu 2 and Phe, where it
was 1 m M.
Ribosomes programmed with poly(A), or with poly(U) carrying
AcPhe-tRNAPhe in the P site were prepared in buffer B (50 mM Tris-
HCl, pH 7.5, 50 mM NH4Cl, 10 mM MgCl2, 1 mM DTT) and used for
kinetic measurements of A site binding as described1,2. Rate con-
stants were calculated from combined sets of time courses for
proflavin fluorescence changes, GTP hydrolysis and dipeptide for-
mation measured at five different ribosome concentrations. The
data were globally fitted by numerical integration according to
the mechanism of Fig. 1 using Scientist for Windows software
(MicroMath Scientific Software, Salt Lake City)1,2. The fit yielded a
unique solution for the rate constants k2–k7 as well as for the
remaining fluorescence factors, provided that the values for 
k1, k-1, k-2, and for the relative fluorescence of aa-tRNA in the ini-
tial binding complex were fixed. For k5 and k7, the same values
were also obtained analytically. For values that were measured
directly, standard deviations were calculated from the variation
of several experiments. For values calculated by global fitting, the
standard deviation for one parameter was determined for the
case when all other parameters, except the ones measured direct-
ly, were allowed to change. That is, if a given parameter was set
to a value outside the range of standard deviation, no fit satisfy-
ing all data sets could be obtained. This was particularly the case
when the attempt was made to fit the data sets obtained in the
presence of paromomycin using the parameters obtained in the
absence of paromomycin.
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